openPR Logo
Press release

Increased Digital Device Usage Fueling Growth In The OTC Dry Eye Drops Market: Pivotal Factor Influencing OTC Dry Eye Drops Market Growth in 2025

09-15-2025 10:12 AM CET | Health & Medicine

Press release from: The Business Research Company

OTC Dry Eye Drops

OTC Dry Eye Drops

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

OTC Dry Eye Drops Market Size Growth Forecast: What to Expect by 2025?
The dry eye drops market on the Over-The-Counter (OTC) has seen considerable expansion in recent times. The industry is poised to surge from $3.49 billion in 2024 to $3.77 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 7.8%. The acceleration during the historic period can be linked to several factors such as the growing use of digital gadgets, lifestyle modifications, a surge in vision-impairing conditions, increased duration spent in front of screens, and the widespread usage of contact lenses.

How Will the OTC Dry Eye Drops Market Size Evolve and Grow by 2029?
In the coming years, the OTC dry eye drops market is anticipated to witness robust growth, projecting a size of "$5.04 billion by 2029 at an annual compound growth rate (CAGR) of 7.5%. This growth can be credited to factors such as an increasing aging populace, heightened eye health awareness, growing health-focused mindset, higher incidence of dry eye syndrome, and augmented consumer awareness. The forecast period will likely see trends including technological breakthroughs, advancements in formulation techniques, increase in partnerships, product innovation, and the rise of hydrogel technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/otc-dry-eye-drops-global-market-report

What Drivers Are Propelling the Growth of OTC Dry Eye Drops Market Forward?
Growth in the OTC dry eye drops market is predicted to be driven by the escalating usage of digital devices. These devices, which use digital technology to process data or carry out specific tasks, have seen a surge in popularity due to several factors, including their compact size, consumer demand, digital transition, the emergence of the Internet of Things, and the overall shift towards a digital lifestyle. OTC dry eye drops offer an effective and easy solution to dry eye symptoms potentially arising from regular or extended usage of digital devices, ensuring individuals can uphold their eye comfort and clarity of vision in our increasingly digital society. To illustrate, Uswitch Limited, a financial conduct authority based in the UK, reported in February 2024 that mobile connections had seen a 3.8% increase from the previous year, totaling 71.8 million in 2022- an addition of roughly 2.6 million connections. By 2025, the UK population is expected to reach 68.3 million, with around 65 million, or 95% of the entire population, predicted to own smartphones. This trend of increasing digital device usage is, thus, fuelling the expansion of the OTC dry eye drops market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15629&type=smp

Which Emerging Trends Are Transforming the OTC Dry Eye Drops Market in 2025?
Leading businesses in the over-the-counter (OTC) dry eye drops industry are concentrating on bringing new and innovative goods to the market, such as lubricant eye drops without preservatives, in order to maintain their dominance. These OTC lubricant eye drops are formulated to alleviate dry and irritable eyes, without the inclusion of any preservatives. For example, Alcon Inc., a Swiss-based medical device firm that specializes in eye care products, launched its Systane Complete Preservative-Free Lubricant Eye Drops in Europe in January 2022. Its unique moisture and lipid delivery mechanism ensures even distribution across the ocular surface, effectively addressing dryness. The product utilizes advanced nanodroplet technology for quick hydration, tear evaporation defense, and sustained relief. The eye drops come in a user-friendly, multi-dose bottle facilitated by proprietary PureFlow technology, which uses a one-way valve to prevent contamination and thus eliminates the necessity for preservatives.

What Are the Key Segments in the OTC Dry Eye Drops Market?
The otc dry eye drops market covered in this report is segmented -

1) By Type: Generics, Branded
2) By Product: Preservatives Free, With Preservatives
3) By Viscosity: High Viscosity, Low Viscosity
4) By Distribution Channel: Online Pharmacies, Drugstores And Supermarkets, Retail Pharmacies, Other Distribution Channels

Subsegments:
1) By Generics: Artificial Tears (Non-Prescription), Lubricating Drops, Moisturizing Eye Drops, Rewetting Drops For Contact Lens Wearers
2) By Branded: Brand-Specific Artificial Tears (Blink, Systane, Refresh), Prescription-To-Otc Switch Brands, Premium Lubricating Drops (With Added Ingredients Like Hyaluronic Acid, Vitamins)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15629&type=smp

Who Are the Key Players Shaping the OTC Dry Eye Drops Market's Competitive Landscape?
Major companies operating in the OTC dry eye drops market are Pfizer Inc., Johnson & Johnson Services Inc., Novartis International AG, Allergan plc, Otsuka Pharmaceutical Co. Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Prestige Consumer Healthcare Inc., AFT Pharmaceuticals Ltd., Sentiss Pharma Private Limited, VISUfarma B.V., Ursapharm Arzneimittel GmbH, Thea Pharmaceuticals Inc., Horus Pharma, Oasis Medical, Novaliq GmbH, Medicom Healthcare Ltd., Similasan AG, Altaire Pharmaceutical Inc.

What Geographic Markets Are Powering Growth in the OTC Dry Eye Drops Market?
North America was the largest region in the OTC dry eye drops market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the OTC dry eye drops market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15629

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increased Digital Device Usage Fueling Growth In The OTC Dry Eye Drops Market: Pivotal Factor Influencing OTC Dry Eye Drops Market Growth in 2025 here

News-ID: 4182486 • Views:

More Releases from The Business Research Company

Soaring Demand Set to Propel Tetanus Toxoid Vaccine Market to $6.98 Billion by 2029
Soaring Demand Set to Propel Tetanus Toxoid Vaccine Market to $6.98 Billion by 2 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Tetanus Toxoid Vaccine Market Through 2025? In recent years, there has been a substantial growth in the market size of the tetanus toxoid vaccine. The market is expected to soar from $5.08 billion in 2024 to $5.41 billion in 2025, marking a
Unlocking Opportunities in the Rheumatology Therapeutics Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Rheumatology Therapeutics Market: 2025-2034 Forec …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Rheumatology Therapeutics Industry Market Size Be by 2025? In recent years, the rheumatology therapeutics market dimensions have seen consistent growth. Predicted to rise from $42.4 billion in 2024 to $44.18 billion in 2025, this represents a compound annual growth rate (CAGR) of 4.2%. This growth during
Transformative Trends Impacting the Peripheral Vasodilator Drugs Market Landscape: Innovation In Peripheral Vasodilator Market With Advanced Drug Development
Transformative Trends Impacting the Peripheral Vasodilator Drugs Market Landscap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Peripheral Vasodilator Drugs Market Size By 2025? The market for peripheral vasodilator drugs has dramatically increased in past few years. The market size is projected to expand from $6.27 billion in 2024 to about $6.61 billion in 2025, with a compound annual growth rate (CAGR)
mRNA Cancer Vaccines And Therapeutics Market on Track for Strong Growth, Estimated to Grow at 15.2% CAGR Through 2029
mRNA Cancer Vaccines And Therapeutics Market on Track for Strong Growth, Estimat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the mRNA Cancer Vaccines And Therapeutics Market Through 2025? There has been a swift expansion of the mRNA cancer vaccines and therapeutics market size over the past few years. The market is set to increase from the recorded $61.52 billion in 2024 to

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to